Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators

Cengiz Ermis; Alan X. Zhu; Laura Vanheel; Mary Jo Lemke; Scott Sakaguchi; Keith G. Lurie; Fei Lu; Joseph Lin; David G. Benditt

doi:10.1016/j.amjcard.2005.03.051

Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators

Cengiz Ermis
, Alan X. Zhu
, Laura Vanheel
, Mary Jo Lemke
, Scott Sakaguchi
, Keith G. Lurie
, Fei Lu
, Joseph Lin
, David G. Benditt

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Implantable cardioverter defibrillators have been shown to provide similar survival benefits for patients who have left ventricular dysfunction due to ischemic heart disease and for subsets of patients who have nonischemic cardiomyopathy. Findings in this study extend these observations by showing that patients who have ischemic or nonischemic heart disease and receive implantable cardioverter defibrillators not only have comparable mortality rates but also similar tachyarrhythmia frequencies during follow-up; further, mortality and tachyarrhythmia outcomes are independent of initial arrhythmia indication.

Original language	English (US)
Pages (from-to)	233-238
Number of pages	6
Journal	American Journal of Cardiology
Volume	96
Issue number	2
DOIs	https://doi.org/10.1016/j.amjcard.2005.03.051
State	Published - Jul 15 2005

Bibliographical note

Funding Information:
Dr. Ermis was supported in part by the Midwest Arrhythmia Research Foundation, Edina, Minnesota. Grant funding was received from the Midwest Arrhythmia Research Foundation, Edina, Minnesota, and from Medtronic Inc., Minneapolis, Minnesota. Dr. Lin was supported in part by an LRP grant from the National Institutes of Health, Bethesda, Maryland.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1016/j.amjcard.2005.03.051

Find It

Find It at U of M Libraries

Cite this

Ermis, C., Zhu, A. X., Vanheel, L., Lemke, M. J., Sakaguchi, S., Lurie, K. G., Lu, F., Lin, J., & Benditt, D. G. (2005). Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators. American Journal of Cardiology, 96(2), 233-238. https://doi.org/10.1016/j.amjcard.2005.03.051

Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators. / Ermis, Cengiz; Zhu, Alan X.; Vanheel, Laura et al.
In: American Journal of Cardiology, Vol. 96, No. 2, 15.07.2005, p. 233-238.

Research output: Contribution to journal › Article › peer-review

Ermis, C, Zhu, AX, Vanheel, L, Lemke, MJ, Sakaguchi, S, Lurie, KG, Lu, F, Lin, J & Benditt, DG 2005, 'Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators', American Journal of Cardiology, vol. 96, no. 2, pp. 233-238. https://doi.org/10.1016/j.amjcard.2005.03.051

@article{6c675696680e4dcdba815c6b8c93607a,

title = "Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators",

abstract = "Implantable cardioverter defibrillators have been shown to provide similar survival benefits for patients who have left ventricular dysfunction due to ischemic heart disease and for subsets of patients who have nonischemic cardiomyopathy. Findings in this study extend these observations by showing that patients who have ischemic or nonischemic heart disease and receive implantable cardioverter defibrillators not only have comparable mortality rates but also similar tachyarrhythmia frequencies during follow-up; further, mortality and tachyarrhythmia outcomes are independent of initial arrhythmia indication.",

author = "Cengiz Ermis and Zhu, \{Alan X.\} and Laura Vanheel and Lemke, \{Mary Jo\} and Scott Sakaguchi and Lurie, \{Keith G.\} and Fei Lu and Joseph Lin and Benditt, \{David G.\}",

note = "Funding Information: Dr. Ermis was supported in part by the Midwest Arrhythmia Research Foundation, Edina, Minnesota. Grant funding was received from the Midwest Arrhythmia Research Foundation, Edina, Minnesota, and from Medtronic Inc., Minneapolis, Minnesota. Dr. Lin was supported in part by an LRP grant from the National Institutes of Health, Bethesda, Maryland. ",

year = "2005",

month = jul,

day = "15",

doi = "10.1016/j.amjcard.2005.03.051",

language = "English (US)",

volume = "96",

pages = "233--238",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators

AU - Ermis, Cengiz

AU - Zhu, Alan X.

AU - Vanheel, Laura

AU - Lemke, Mary Jo

AU - Sakaguchi, Scott

AU - Lurie, Keith G.

AU - Lu, Fei

AU - Lin, Joseph

AU - Benditt, David G.

N1 - Funding Information: Dr. Ermis was supported in part by the Midwest Arrhythmia Research Foundation, Edina, Minnesota. Grant funding was received from the Midwest Arrhythmia Research Foundation, Edina, Minnesota, and from Medtronic Inc., Minneapolis, Minnesota. Dr. Lin was supported in part by an LRP grant from the National Institutes of Health, Bethesda, Maryland.

PY - 2005/7/15

Y1 - 2005/7/15

N2 - Implantable cardioverter defibrillators have been shown to provide similar survival benefits for patients who have left ventricular dysfunction due to ischemic heart disease and for subsets of patients who have nonischemic cardiomyopathy. Findings in this study extend these observations by showing that patients who have ischemic or nonischemic heart disease and receive implantable cardioverter defibrillators not only have comparable mortality rates but also similar tachyarrhythmia frequencies during follow-up; further, mortality and tachyarrhythmia outcomes are independent of initial arrhythmia indication.

AB - Implantable cardioverter defibrillators have been shown to provide similar survival benefits for patients who have left ventricular dysfunction due to ischemic heart disease and for subsets of patients who have nonischemic cardiomyopathy. Findings in this study extend these observations by showing that patients who have ischemic or nonischemic heart disease and receive implantable cardioverter defibrillators not only have comparable mortality rates but also similar tachyarrhythmia frequencies during follow-up; further, mortality and tachyarrhythmia outcomes are independent of initial arrhythmia indication.

UR - https://www.scopus.com/pages/publications/22144477233

UR - https://www.scopus.com/pages/publications/22144477233#tab=citedBy

U2 - 10.1016/j.amjcard.2005.03.051

DO - 10.1016/j.amjcard.2005.03.051

M3 - Article

C2 - 16018849

AN - SCOPUS:22144477233

SN - 0002-9149

VL - 96

SP - 233

EP - 238

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 2

ER -

Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this